Not applicableEnded earlyNCT05184283What this trial is testingUtilization of MAsS in Patients Undergoing LT for HCCWho this might be right forNAFLDHepatocellular CarcinomaLiver Diseases+3 more Columbia University 11
Testing effectiveness (Phase 2)UnknownNCT02839954What this trial is testingCAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid TumorWho this might be right forHepatocellular CarcinomaNon-small Cell Lung CancerPancreatic Carcinoma+4 more PersonGen BioTherapeutics (Suzhou) Co., Ltd. 10
Testing effectiveness (Phase 2)Ended earlyNCT02102022What this trial is testingPh 1-2 Study ADI-PEG 20 Plus FOLFOX in Subjects With Advanced GI Malignancies Focusing on Hepatocellular CarcinomaWho this might be right forAdvanced Gastrointestinal (GI) MalignanciesHepatocellular CarcinomaGastric Cancer+1 more Polaris Group 140
Not applicableStudy completedNCT00857805What this trial is testingTransarterial Chemoembolization Versus Proton Beam Radiotherapy for the Treatment of Hepatocellular CarcinomaWho this might be right forCarcinoma, Hepatocellular Loma Linda University 76
Testing effectiveness (Phase 2)Looking for participantsNCT07219459What this trial is testingVisugromab, Nivolumab and Lenvatinib Compared to Double Placebo and Lenvatinib in Unresectable or Metastatic Hepatocellular Carcinoma Post Anti-PD-(L)1 FailureWho this might be right forUnresectable or Metastatic Hepatocellular CarcinomaChild-Pugh A Hepatocellular CarcinomaFailure of First-Line Treatment That Included an Approved Anti PD-(L)1 Compound CatalYm GmbH 104
Early research (Phase 1)Ended earlyNCT03144661What this trial is testingAn Open-Label Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other MalignanciesWho this might be right forHepatocellular Carcinoma (HCC)CholangiocarcinomaEsophageal Cancer+3 more Incyte Corporation 25
Post-approval studies (Phase 4)Looking for participantsNCT05185505What this trial is testingAtezolizumab and Bevacizumab Pre-Liver Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan CriteriaWho this might be right forHepatocellular CarcinomaHepatocellular Cancer The Methodist Hospital Research Institute 24
Testing effectiveness (Phase 2)UnknownNCT00805896What this trial is testingSongyou Granule and Transarterial Chemoembolization for Hepatocellular CarcinomaWho this might be right forHepatocellular CarcinomaUnresectable Fudan University 260
Testing effectiveness (Phase 2)Looking for participantsNCT07410494What this trial is testingBiomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid TumorsWho this might be right forCancerBreast CancerNon-Small Cell Lung Cancer (NSCLC)+10 more Essen Biotech 85
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07682454What this trial is testingUtilize Imaging to Assess Changes in Hepatocellular Carcinoma Perfusion as Potentiated by Intra-Arterial NitroglycerinWho this might be right forHepatocellular Carcinoma (HCC)Liver Cancer, Adult University of California, San Francisco 50
Large-scale testing (Phase 3)Ended earlyNCT02867280What this trial is testingSorafenib Treatment in Patients With Hepatocellular Carcinoma With Microvascular Invasion After Radical ResectionWho this might be right forHepatocellular CarcinomaRecurrence Sun Yat-sen University 154
Large-scale testing (Phase 3)Study completedNCT03062358What this trial is testingStudy of Pembrolizumab (MK-3475) or Placebo Given With Best Supportive Care in Asian Participants With Previously Treated Advanced Hepatocellular Carcinoma (MK-3475-394/KEYNOTE-394)Who this might be right forCarcinoma, Hepatocellular Merck Sharp & Dohme LLC 453
Large-scale testing (Phase 3)Active Not RecruitingNCT03017326What this trial is testingPaediatric Hepatic International Tumour TrialWho this might be right forHepatoblastomaCarcinoma, Hepatocellular University of Birmingham 450
Testing effectiveness (Phase 2)Looking for participantsNCT06031285What this trial is testingPerioperative Sintilimab Plus Bevacizumab Biosimilar and TACE-HAIC for HCC Patients With PVTT: A Phase-2 Clinical TrialWho this might be right forHepatocellular Carcinoma Sun Yat-sen University 43
Testing effectiveness (Phase 2)UnknownNCT06085976What this trial is testingEfficacy and Safety of Octreotide in Laparoscopic Hepatectomy Surgery: Effect on Blood Loss, Need for Vasoactive Drugs, Transfusion Requirements.Who this might be right forHepatic CarcinomaHepatic Metastasis Clinica Universidad de Navarra, Universidad de Navarra 62
Early research (Phase 1)Active Not RecruitingNCT07118176What this trial is testingDetermining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic CancersWho this might be right forAnal CarcinomaBladder CarcinomaBreast Carcinoma+31 more Jonsson Comprehensive Cancer Center 30
Very early researchLooking for participantsNCT06418659What this trial is testingA Clinical Trial Evaluating the Safety and Efficacy of Intravenous CD-801 in Treating Advanced HCC PatientsWho this might be right forAdvanced Hepatocellular Carcinoma Shanghai Changzheng Hospital 37
Testing effectiveness (Phase 2)Study completedNCT02560779What this trial is testingTrial of TRC105 and Sorafenib in Patients With HCCWho this might be right forHepatocellular Carcinoma Tracon Pharmaceuticals Inc. 27
Early research (Phase 1)Study completedNCT00049296What this trial is testingThalidomide and Docetaxel in Treating Patients With Advanced CancerWho this might be right forCancer Case Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Study completedNCT00775073What this trial is testingAntiangiogenic Treatment of Hepatocellular Cancer With Bevacizumab and RAD001Who this might be right forHepatocellular Carcinoma Gerhard Treiber 33